137 related articles for article (PubMed ID: 38920744)
1. Health Economic Evaluation of Lung Cancer Screening Using a Diagnostic Blood Test: The Early Detection of Cancer of the Lung Scotland (ECLS).
Robles-Zurita JA; McMeekin N; Sullivan F; Mair FS; Briggs A
Curr Oncol; 2024 Jun; 31(6):3546-3562. PubMed ID: 38920744
[TBL] [Abstract][Full Text] [Related]
2. Detection in blood of autoantibodies to tumour antigens as a case-finding method in lung cancer using the EarlyCDT®-Lung Test (ECLS): study protocol for a randomized controlled trial.
Sullivan FM; Farmer E; Mair FS; Treweek S; Kendrick D; Jackson C; Robertson C; Briggs A; McCowan C; Bedford L; Young B; Vedhara K; Gallant S; Littleford R; Robertson J; Sewell H; Dorward A; Sarvesvaran J; Schembri S
BMC Cancer; 2017 Mar; 17(1):187. PubMed ID: 28284200
[TBL] [Abstract][Full Text] [Related]
3. Low-dose computed tomography for lung cancer screening in high-risk populations: a systematic review and economic evaluation.
Snowsill T; Yang H; Griffin E; Long L; Varley-Campbell J; Coelho H; Robinson S; Hyde C
Health Technol Assess; 2018 Nov; 22(69):1-276. PubMed ID: 30518460
[TBL] [Abstract][Full Text] [Related]
4. The UK Lung Cancer Screening Trial: a pilot randomised controlled trial of low-dose computed tomography screening for the early detection of lung cancer.
Field JK; Duffy SW; Baldwin DR; Brain KE; Devaraj A; Eisen T; Green BA; Holemans JA; Kavanagh T; Kerr KM; Ledson M; Lifford KJ; McRonald FE; Nair A; Page RD; Parmar MK; Rintoul RC; Screaton N; Wald NJ; Weller D; Whynes DK; Williamson PR; Yadegarfar G; Hansell DM
Health Technol Assess; 2016 May; 20(40):1-146. PubMed ID: 27224642
[TBL] [Abstract][Full Text] [Related]
5. The cost-effectiveness of the Manchester 'lung health checks', a community-based lung cancer low-dose CT screening pilot.
Hinde S; Crilly T; Balata H; Bartlett R; Crilly J; Barber P; Threlfall A; Tonge J; Booton R; Crosbie PA
Lung Cancer; 2018 Dec; 126():119-124. PubMed ID: 30527175
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness and health impact of lung cancer screening with low-dose computed tomography for never smokers in Japan and the United States: a modelling study.
Kowada A
BMC Pulm Med; 2022 Jan; 22(1):19. PubMed ID: 34996423
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of screening for lung cancer with low-dose computed tomography: a systematic literature review.
Puggina A; Broumas A; Ricciardi W; Boccia S
Eur J Public Health; 2016 Feb; 26(1):168-75. PubMed ID: 26370440
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of lung MRI in lung cancer screening.
Allen BD; Schiebler ML; Sommer G; Kauczor HU; Biederer J; Kruser TJ; Carr JC; Hazen G
Eur Radiol; 2020 Mar; 30(3):1738-1746. PubMed ID: 31748855
[TBL] [Abstract][Full Text] [Related]
9. Risk-Targeted Lung Cancer Screening: A Cost-Effectiveness Analysis.
Kumar V; Cohen JT; van Klaveren D; Soeteman DI; Wong JB; Neumann PJ; Kent DM
Ann Intern Med; 2018 Feb; 168(3):161-169. PubMed ID: 29297005
[TBL] [Abstract][Full Text] [Related]
10. Cost-Effectiveness Analysis of Lung Cancer Screening in the United States: A Comparative Modeling Study.
Criss SD; Cao P; Bastani M; Ten Haaf K; Chen Y; Sheehan DF; Blom EF; Toumazis I; Jeon J; de Koning HJ; Plevritis SK; Meza R; Kong CY
Ann Intern Med; 2019 Dec; 171(11):796-804. PubMed ID: 31683314
[TBL] [Abstract][Full Text] [Related]
11. Trade-off between benefits, harms and economic efficiency of low-dose CT lung cancer screening: a microsimulation analysis of nodule management strategies in a population-based setting.
Treskova M; Aumann I; Golpon H; Vogel-Claussen J; Welte T; Kuhlmann A
BMC Med; 2017 Aug; 15(1):162. PubMed ID: 28838313
[TBL] [Abstract][Full Text] [Related]
12. Biennial lung cancer screening in Canada with smoking cessation-outcomes and cost-effectiveness.
Goffin JR; Flanagan WM; Miller AB; Fitzgerald NR; Memon S; Wolfson MC; Evans WK
Lung Cancer; 2016 Nov; 101():98-103. PubMed ID: 27794416
[TBL] [Abstract][Full Text] [Related]
13. Performance and Cost-Effectiveness of Computed Tomography Lung Cancer Screening Scenarios in a Population-Based Setting: A Microsimulation Modeling Analysis in Ontario, Canada.
Ten Haaf K; Tammemägi MC; Bondy SJ; van der Aalst CM; Gu S; McGregor SE; Nicholas G; de Koning HJ; Paszat LF
PLoS Med; 2017 Feb; 14(2):e1002225. PubMed ID: 28170394
[TBL] [Abstract][Full Text] [Related]
14. Estimating the Cost-Effectiveness of Lung Cancer Screening with Low-Dose Computed Tomography for High-Risk Smokers in Australia.
Wade S; Weber M; Caruana M; Kang YJ; Marshall H; Manser R; Vinod S; Rankin N; Fong K; Canfell K
J Thorac Oncol; 2018 Aug; 13(8):1094-1105. PubMed ID: 29689434
[TBL] [Abstract][Full Text] [Related]
15. Resource utilization and costs during the initial years of lung cancer screening with computed tomography in Canada.
Cressman S; Lam S; Tammemagi MC; Evans WK; Leighl NB; Regier DA; Bolbocean C; Shepherd FA; Tsao MS; Manos D; Liu G; Atkar-Khattra S; Cromwell I; Johnston MR; Mayo JR; McWilliams A; Couture C; English JC; Goffin J; Hwang DM; Puksa S; Roberts H; Tremblay A; MacEachern P; Burrowes P; Bhatia R; Finley RJ; Goss GD; Nicholas G; Seely JM; Sekhon HS; Yee J; Amjadi K; Cutz JC; Ionescu DN; Yasufuku K; Martel S; Soghrati K; Sin DD; Tan WC; Urbanski S; Xu Z; Peacock SJ;
J Thorac Oncol; 2014 Oct; 9(10):1449-58. PubMed ID: 25105438
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of a low-dose computed tomography screening programme for lung cancer in New Zealand.
Jaine R; Kvizhinadze G; Nair N; Blakely T
Lung Cancer; 2018 Oct; 124():233-240. PubMed ID: 30268467
[TBL] [Abstract][Full Text] [Related]
17. Population-Based Screening Using Low-Dose Chest Computed Tomography: A Systematic Review of Health Economic Evaluations.
Behr CM; Oude Wolcherink MJ; IJzerman MJ; Vliegenthart R; Koffijberg H
Pharmacoeconomics; 2023 Apr; 41(4):395-411. PubMed ID: 36670332
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of lung cancer screening with low-dose computed tomography in heavy smokers: a microsimulation modelling study.
Du Y; Sidorenkov G; Heuvelmans MA; Groen HJM; Vermeulen KM; Greuter MJW; de Bock GH
Eur J Cancer; 2020 Aug; 135():121-129. PubMed ID: 32563896
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of Low-Dose Computed Tomography With a Plasma-Based Biomarker for Lung Cancer Screening in China.
Zhao Z; Wang Y; Wu W; Yang Y; Du L; Dong H
JAMA Netw Open; 2022 May; 5(5):e2213634. PubMed ID: 35608858
[TBL] [Abstract][Full Text] [Related]
20. EarlyCDT Lung blood test for risk classification of solid pulmonary nodules: systematic review and economic evaluation.
Duarte A; Corbett M; Melton H; Harden M; Palmer S; Soares M; Simmonds M
Health Technol Assess; 2022 Dec; 26(49):1-184. PubMed ID: 36534989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
